Related Experiment Video

Updated: Mar 15, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.6K

Localized oral mucous membrane pemphigoid: successful topical treatment with 1% tacrolimus solution as

F Al-Shehhi1,2, G Balakirski1, J Baratli1

  • 1Department of Dermatology and Allergology, Universitiy Hospital of Aachen, Aachen, Germany.

Journal of the European Academy of Dermatology and Venereology : JEADV
|August 26, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.4K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.6K
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.4K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

596
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
596
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

639
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
639

Articles linked to this work by shared authors, journal, and citation graph.

From natural wood to high-performance composites: role of fiber treatment and graphene nanoplatelets.

Scientific reports·2026

Enhancing the tensile performance of GFRE composites: a comparative study of micro- and nano-copper fillers.

Scientific reports·2026

Influence of curing pressure and surface treatment on mechanical properties of hybrid fiber metal laminates.

Scientific reports·2026

Advanced hybrid nanocomposites for infrastructure renewal: enhanced shear and flexural performance in load-bearing applications.

Scientific reports·2026

Effect of infill parameters and thermal annealing on the mechanical behavior of FDM 3D-printed polymer.

Scientific reports·2026

Insights into particle dispersion and damage mechanisms in functionally graded metal matrix composites with random microstructure-based finite element model.

Scientific reports·2024

52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Five-year survival impact of adjuvant anti-PD-1 therapy in a nationwide cohort of stage III melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Prevalence, predictors and psychological conditions of tanning behavioural addiction - A meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Primary Chest Wall Malignant Lymphoma in a Patient Without a History of Tuberculosis or Chronic Pyothorax: A Case Report With a Review of the Literature.

Cureus·2026

Acute-onset dysphagia: an uncommon presentation of myasthenia crisis.

BMJ case reports·2026

RGS6 is a key regulator of itch in female mice.

Neuroscience letters·2026

Evaluation of the predictive value of sCD200 and sCD200R for disease severity and relapse in myasthenia gravis.

Clinica chimica acta; international journal of clinical chemistry·2026

Ibero-American consensus on reactive arthritis: definition, diagnosis, and management.

Clinical rheumatology·2026

Mast cell-derived extracellular vesicles in lung diseases: roles in pulmonary inflammation, immune regulation, and microenvironmental remodeling.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us